HyperglycemiaHypoglycemiaDiabetes Mellitus, Type 1Diabetes MellitusDiabetes Mellitus, Type 2Blood GlucoseDiabetes Mellitus, ExperimentalInsulinDiabetes ComplicationsHypoglycemic AgentsHemoglobin A, GlycosylatedGlucoseDiabetes, GestationalGlucagonGlucose Tolerance TestStreptozocinHyperinsulinismIslets of LangerhansRisk FactorsGlucose Clamp TechniqueBlood Glucose Self-MonitoringInsulin ResistanceC-PeptideInsulin-Secreting CellsFastingDiabetic NephropathiesInsulin Infusion SystemsTime FactorsPregnancy in DiabeticsEpinephrineObesityGlucose IntoleranceDiabetic NeuropathiesDiabetic KetoacidosisPrediabetic StateDiabetic RetinopathyPostprandial PeriodDiabetes InsipidusRetrospective StudiesSulfonylurea CompoundsMetforminGluconeogenesisPancreatic PolypeptideProspective StudiesPrevalencePancreasReference ValuesTreatment OutcomeGlucokinaseBody WeightInsulin, Long-ActingCohort StudiesGlucagon-Like Peptide 1LiverMice, Inbred NODFollow-Up StudiesPregnancyRats, Sprague-DawleyRats, Inbred BBBody Mass IndexIncidenceBiological MarkersDisease Models, AnimalFatty Acids, NonesterifiedCardiovascular DiseasesInfant, NewbornHomeostasisIslets of Langerhans TransplantationAlloxanCross-Sectional StudiesCase-Control StudiesRats, WistarDipeptidyl-Peptidase IV InhibitorsClinical AlarmsDiabetic AngiopathiesPancreas, ArtificialDiabetic DietAlbuminuriaGlycosuriaSensitivity and SpecificityPredictive Value of TestsAge FactorsOxidative StressInsulin ComaGlipizideInsulinomaVenomsDelayed DiagnosisPhlorhizinHydrocortisoneEarly DiagnosisRats, ZuckerHypertensionProinsulinBlood PressureUnited StatesMetabolic Syndrome XRisk AssessmentGlycosylation End Products, AdvancedCritical Illness